Global Pharmaceutical Intermediates Market Analysis Trends, Applications, Analysis, Growth, and Forecast to 2027
Request Covid 19 Impact
Why Choose Us
- 360 Degree Approach
- Growth Consulting
- 24/7 Research Support
- Comprehensive-Level of Customization
- Comprehensive-Level of Customization
- Competitive Intelligence
- Single-Country/ Region Intelligence
- Post-Sale Service Assistance
- Access to Lead Analysts
- Available in PDF, Excel, Word/ PPT
Pharmaceutical Intermediates Market Overview:
Pharmaceutical Intermediates Market was valued at $24 million in 2020 & is projected to reach $34 million by 2030. It is expected to grow at a 5% CAGR between 2021 and 2030.
Pharmaceutical Intermediates Market Report offers in-depth insights, revenue details, and other vital information regarding the global pharmaceutical intermediates market and the various trends, drivers, restraints, opportunities, and threats in the target market till 2027.
The Pharmaceutical Intermediates Market report offers insightful and detailed information regarding the various key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint.
The global pharmaceutical intermediates market report has been segmented on the basis of product type, application, distribution channel, and region.
An active pharmaceutical ingredient is a substance that is intended to supply pharmacological activity or other direct effects in the diagnosis, cure, mitigation, treatment, or prevention of disease. Pharmaceutical intermediates are chemical compounds that are building blocks used in the production of active pharmaceutical ingredients.
Pharmaceutical intermediates are produced during the process of manufacturing or synthesis of active pharmaceutical ingredients.
These pharmaceutical intermediates further undergo molecular changes and processing before becoming active pharmaceutical ingredients.
Pharmaceutical Intermediates Market Dynamics:
The increasing prevalence of various diseases across the globe is a major factor driving the growth of the global pharmaceutical intermediates market.
In addition, increasing government expenditure on the pharmaceuticals sector in developing countries, coupled with rising research and development activities for the development of new innovative and advanced products are other factors expected to support the growth of the global market over the forecast period.
Moreover, rising disposable income, changing lifestyle patterns which is results in the increasing number of people suffering from various diseases, and a rising number of the geriatric population prone to various diseases are some other major factors increasing demands for various medicine, which in turn is expected to support the growth of the target market.
Furthermore, increasing demand for a generic drug is expected to boost the production of active pharmaceutical ingredients which in turn is expected to further drive the growth of the market to a certain extent.
However, stringent regulations related to product approval are a major factor expected to hamper the growth of the market to a certain extent.
Technological advancements and increasing R&D activities by major players for novel product offerings are expected to create new opportunities in terms of revenue for players operating in the target market over the forecast period.
In addition, the growing public-private partnership in developing countries is expected to create revenue opportunities that are expected to support the growth of the market to a certain extent.
Pharmaceutical Intermediates Market Region Analysis:
The market in North America is expected to dominate the global market and is expected to continue its dominance over the forecast period.
This can be attributed to the well-developed pharmaceutical sector and the presence of major manufacturers in the countries in this region.
The Asia Pacific is expected to witness faster growth, owing to increasing government expenditure on the pharmaceutical sector, and growing merger and acquisition activities among regional and international players in emerging economies in this region.
In 2017, according to India Brand Equity Foundation, India exported pharmaceutical products worth US$ 16.89 Bn. The market in Europe is expected to contribute significant revenue share in the global market.
Global Pharmaceutical Intermediates Market Segmentation:
By Product Type:
- Antipyretic analgesics
By Distribution Channel:
- Direct Sales
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Attribute Report Details Market Size Ask For Market Size Growth Rate Ask For Growth Rate Key Companies Ask For Companies Report Coverage Revenue analysis, Competitive landscape, Key company analysis, Market Trends, Key segments, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis and more… Historical Data Period 2015-2020 Base Year 2022 Forecast Period 2022-2031 Region Scope North America, Europe, Asia-Pacific, South America, Middle East & Africa Country Scope United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa Revenue in US$ Mn
- Aceto Corporation
- Easter Chemical Corporation
- BASF SE
- Midas Pharma GmbH
- R. Life Sciences Private Limited
- Lianhe Chemical Technology Co Ltd.
- Dishman Pharmaceuticals and Chemicals Limited
- Codexis, Inc.
- Sanofi Winthrop Industrie S.A.
- Vertellus Holdings LLC
- Dextra Laboratories Limited,
- Chemcon Specialty Chemical Pvt. Ltd.
- ZCL Chemical Ltd.
Request for TOC
Don't just take our word. We are trusted by these great companies!